Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivin

被引:101
作者
Xing, NZ
Qian, JQ
Bostwick, D
Bergstralh, E
Young, CYF
机构
[1] Mayo Clin & Mayo Fdn, Mayo Grad Sch, Dept Urol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Mayo Grad Sch, Dept Biochem & Mol Biol, Rochester, MN 55905 USA
[3] Bostwick Labs, Richmond, VA USA
[4] Mayo Clin & Mayo Fdn, Mayo Grad Sch, Biostat Sect, Rochester, MN 55905 USA
关键词
prostate; adenocarcinoma; neuroendocrine; chromogranin A; survivin; apoptosis;
D O I
10.1002/pros.1076
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. Neuroendocrine (NE) differentiation may be related to the growth and progression of prostate cancer, especially androgen-insensitive tumors. Recently the overexpression of a new anti-apoptosis protein, survivin, has attracted attention for its potential implication in many human cancers. The fact that NE cells in prostate are bcl-2 negative prompted us to investigate if the prostatic NE cells over-express survivin. MATERIALS AND METHODS. Double immunohistochemical staining and immunofluorescence of chromogranin A (CgA) and survivin were performed in 57 patients with localized prostate cancer who underwent radical prostatectomy. The terminal deoxynucleotidyl transferase (TDT)-mediated dUTP-digoxigenin nick end-labeling (TUNEL) method was used for apoptosis detection in three prostate cancer specimens with NE differentiation. The relationship between NE differentiation and clinicopathological characteristics, disease progression as well as patient survival, were analyzed retrospectively. RESULTS. It was found that NE cells in both benign and malignant prostate tissues overexpressed the anti-apoptosis protein survivin. While apoptosis was detected in non-NE epithelial cells, all NE cells were negative for apoptosis detection. During the period of followup, 17 (63%) of 27 patients with NE differentiation had prostate cancer progression, while 12 (40%) of 30 patients without NE differentiation had systemic prostate cancer progression. 10 (37%) of 27 patients with NE differentiation died from prostate cancer during the period of follow up, while 6 (20%) of 30 patients without NE differentiation died from prostate cancer. However, none of these characteristics reached statistical significance, probably because of the small number of cases enrolled. CONCLUSIONS. This study discovers that all the prostatic NE cells express the new anti-apoptosis protein survivin. This provides a strong molecular basis for the hypothesis that NE cells may endure stressful conditions and escape from apoptosis. While our results suggest a trend of NE differentiation with poorer prognosis, the prognosis implication cannot be concluded due to our small sample size. Prostate 48:7-15, 2001. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:7 / 15
页数:9
相关论文
共 52 条
[1]   PEPTIDE-HORMONEACTIVE AND SEROTONIN-IMMUNOREACTIVE TUMOR-CELLS IN CARCINOMA OF THE PROSTATE [J].
ABRAHAMSSON, PA ;
WADSTROM, LB ;
ALUMETS, J ;
FALKMER, S ;
GRIMELIUS, L .
PATHOLOGY RESEARCH AND PRACTICE, 1987, 182 (03) :298-307
[2]   THE COURSE OF NEURO-ENDOCRINE DIFFERENTIATION IN PROSTATIC CARCINOMAS - AN IMMUNOHISTOCHEMICAL STUDY TESTING CHROMOGRANIN-A AS AN ENDOCRINE MARKER [J].
ABRAHAMSSON, PA ;
FALKMER, S ;
FALT, K ;
GRIMELIUS, L .
PATHOLOGY RESEARCH AND PRACTICE, 1989, 185 (03) :373-380
[3]  
Abrahamsson PA, 1998, PROSTATE, P37
[4]   Anti-apoptosis gene, survivin, and prognosis of neuroblastoma [J].
Adida, C ;
Berrebi, D ;
Peuchmaur, M ;
Reyes-Mugica, M ;
Altieri, DC .
LANCET, 1998, 351 (9106) :882-883
[5]  
Adida C, 1998, AM J PATHOL, V152, P43
[6]  
Adida C, 2000, BLOOD, V96, P1921
[7]   ARE NEUROENDOCRINE CELLS OF PRACTICAL VALUE AS AN INDEPENDENT PROGNOSTIC PARAMETER IN PROSTATE-CANCER [J].
ALLEN, FJ ;
VANVELDEN, DJJ ;
HEYNS, CF .
BRITISH JOURNAL OF UROLOGY, 1995, 75 (06) :751-754
[8]   A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma [J].
Ambrosini, G ;
Adida, C ;
Altieri, DC .
NATURE MEDICINE, 1997, 3 (08) :917-921
[9]   Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting [J].
Ambrosini, G ;
Adida, C ;
Sirugo, G ;
Altieri, DC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (18) :11177-11182
[10]  
Angelsen A, 1997, PROSTATE, V30, P1